← Back to Patent Explorer
US5389686A Expired / Lapsed US ⏱️ 0.0 years remaining

Analgesic properties of fedotozine

Assignee: Jouveinal SA
•
Filing: 1993-07-13
•
Granted: 1995-02-14
•
Expires: 2013-07-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Process for the treatment of painful syndromes, especially local and/or visceral, consisting in the parenteral or topical administration of a therapeutically effective quantity of the (-) tartrate of (+)-(R)-1-[(3,4,5-trimethoxy)benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine.

Inventors

  • 👤 Laurent Diop
  • 👤 Agnes Grouhel
  • 👤 Jean-Louis Junien
  • 👤 Annick Langlois
  • 👤 Xavier Pascaud

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 03:58
CPC Classifications
C; C07; C07C; C07C217/00; C07C217/02; C07C217/48

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 30 words
A method for the treatment of hypersensitivity to pain, which comprises administering to a subject in need of such treatment a therapeutically effective amount of the compound fedotozine (-) tartrate.
Claim 2
Independent Claim 30 words
A method for the treatment of hypersensitivity to pain, which comprises administering to a subject in need of such treatment a therapeutically effective amount of the compound fedotozine (-) tartrate.
Claim 3
Dependent Claim 21 words
The method according to claim 1, wherein a dose of about 5 to 1000 mg of fedotozine (-) tartrate is administered.
Claim 4
Dependent Claim 12 words
The method according to claim 1, wherein the compound is administered parenterally.
Claim 5
Dependent Claim 25 words
The method according to claim 1, wherein the compound is administered in a composition in the form of suppositories, ovules, lotions, creams or aqueous solutions.
Claim 6
Dependent Claim 29 words
The method according to claim 4, wherein the aqueous solutions are administered by perfusion via the i.v. route and contain about 0.01 to 0.5% w/v of (-) fedotozine tartrate.
Claim 7
Dependent Claim 26 words
The method according to claim 4, wherein the aqueous solutions are administered by injection and contain about 0.25 to 2.5% by weight of fedotozine (-) tartrate.
Claim 8
Dependent Claim 33 words
The method according to claim 1 wherein the compound is at least twice as active upon pain induced during a physiological condition of hypersensitivity than upon pain induced during a normal physiological condition.
Claim 9
Independent Claim 30 words
A method for treating pain and producing local analgesia which comprises administering to a subject in need of such treatment a therapeutically effective amount of the compound fedotozine (-) tartrate.
Claim 10
Independent Claim 30 words
A method for treating pain and producing local analgesia which comprises administering to a subject in need of such treatment a therapeutically effective amount of the compound fedotozine (-) tartrate.
Claim 11
Dependent Claim 21 words
The method according to claim 8 wherein a dose of about 5 to 1000 mg of fedotozine (-) tartrate is administered.
Claim 12
Dependent Claim 12 words
The method according to claim 8 wherein the compound is administered parenterally.
Claim 13
Dependent Claim 25 words
The method according to claim 8 wherein the compound is administered in a composition in the form of suppositories, ovules, lotions, creams or aqueous solutions.
Claim 14
Dependent Claim 29 words
The method according to claim 11 wherein the aqueous solutions are administered by perfusion via the i.v. route and contain about 0.01 to 0.5% w/v of fedotozine (-) tartrate.
Claim 15
Dependent Claim 26 words
The method according to claim 11 wherein the aqueous solutions are administered by injection and contain about 0.25 to 2.5% by weight of fedotozine (-) tartrate.

References Cited (Backward Citations)

EP0384088A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-02-13 1998-08-15 1999-02-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-02-13 2002-08-15 2003-02-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-02-13 2006-08-15 2007-02-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag